MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT
From "Reefer Madness" to "This Is Your Brain on Drugs," Americans have lived through decades of anti-cannabis propaganda. Legalization is poised to turn this information environment on its head, unleashing a torrent of corporate-funded, pro-cannabis misinformation that regulators...
Gespeichert in:
Veröffentlicht in: | The American University law review 2022-01, Vol.71 (6), p.2157-2242 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2242 |
---|---|
container_issue | 6 |
container_start_page | 2157 |
container_title | The American University law review |
container_volume | 71 |
creator | Angelatos, David |
description | From "Reefer Madness" to "This Is Your Brain on Drugs," Americans have lived through decades of anti-cannabis propaganda. Legalization is poised to turn this information environment on its head, unleashing a torrent of corporate-funded, pro-cannabis misinformation that regulators cannot prevent or dispel. This appears to be a problem caused by the Supreme Court's creation and expansion over the past fifty years of First Amendment protections for corporate and commercial speech. Although these doctrines contribute substantially to the problem, this Article shows how it originates in lax antitrust policy rather than expansive First Amendment jurisprudence. If Congress follows current legalization trends and facilitates the creation of a consolidated commercial cannabis industry, misinformation about marijuana will follow. That industry will have the opportunity, incentive, and ability to draw on successful disinformation campaigns waged by other big businesses, including the tobacco and food-and-beverage industries, to corrupt both the public's understanding of cannabis science and the science itself. Even with the benefit of foresight, legal institutions are hamstrung in their response to this problem. The First Amendment's protections of corporate and commercial speech foreclose many of the regulatory options. Several options remain, including fraud prosecutions, government speech identifying cannabis's health effects, and administrative regulation of labeling and advertising. But these responses are incomplete, inadequate, and vulnerable to industry capture, constitutional invalidation, and corporate evasion. Ultimately, misinformation about marijuana is an unavoidable cost of a consolidated cannabis industry. Even abolishing the corporate and commercial speech doctrines, although helpful, would not get at the root problem: excessive private power. To effectively address the threat of corporate-funded misinformation about cannabis science, Congress must prevent the creation of a consolidated industry by ratifying and bolstering the existing state bans on interstate and international commerce in cannabis, among other measures. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2761036549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2761036549</sourcerecordid><originalsourceid>FETCH-proquest_journals_27610365493</originalsourceid><addsrcrecordid>eNqNit0KgjAAhUcUZD_vMOg2Ybap2d3SiQu3wZwEQUgXdiGR5fL9s-gBujgcvnO-EXC8iGDXD0I8Bg5CCLse8fEUzKxtPrglxAFnwQsuU6UFNVxJSPeqNFBQzQ8llXQHYyUE0zGnOT99lfUwyULlPPkhlQk0GYOSHWHKdWEgFUwmQ8wCTK6Xm62Xv56DVcpMnLmPrn32tX1VTdt39-GqNmHgIRz4JML_WW8--zv0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761036549</pqid></control><display><type>article</type><title>MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT</title><source>Worldwide Political Science Abstracts</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>HeinOnline Law Journal Library</source><source>Alma/SFX Local Collection</source><creator>Angelatos, David</creator><creatorcontrib>Angelatos, David</creatorcontrib><description>From "Reefer Madness" to "This Is Your Brain on Drugs," Americans have lived through decades of anti-cannabis propaganda. Legalization is poised to turn this information environment on its head, unleashing a torrent of corporate-funded, pro-cannabis misinformation that regulators cannot prevent or dispel. This appears to be a problem caused by the Supreme Court's creation and expansion over the past fifty years of First Amendment protections for corporate and commercial speech. Although these doctrines contribute substantially to the problem, this Article shows how it originates in lax antitrust policy rather than expansive First Amendment jurisprudence. If Congress follows current legalization trends and facilitates the creation of a consolidated commercial cannabis industry, misinformation about marijuana will follow. That industry will have the opportunity, incentive, and ability to draw on successful disinformation campaigns waged by other big businesses, including the tobacco and food-and-beverage industries, to corrupt both the public's understanding of cannabis science and the science itself. Even with the benefit of foresight, legal institutions are hamstrung in their response to this problem. The First Amendment's protections of corporate and commercial speech foreclose many of the regulatory options. Several options remain, including fraud prosecutions, government speech identifying cannabis's health effects, and administrative regulation of labeling and advertising. But these responses are incomplete, inadequate, and vulnerable to industry capture, constitutional invalidation, and corporate evasion. Ultimately, misinformation about marijuana is an unavoidable cost of a consolidated cannabis industry. Even abolishing the corporate and commercial speech doctrines, although helpful, would not get at the root problem: excessive private power. To effectively address the threat of corporate-funded misinformation about cannabis science, Congress must prevent the creation of a consolidated industry by ratifying and bolstering the existing state bans on interstate and international commerce in cannabis, among other measures.</description><identifier>ISSN: 0003-1453</identifier><identifier>EISSN: 1943-5673</identifier><language>eng</language><publisher>Washington: American University Law Review</publisher><subject>Activists ; Advertising ; Alcohol ; Antitrust ; Beverage industry ; Cannabis industry ; Commercial speech ; Commercialization ; Decriminalization ; Enforcement ; False information ; First Amendment-US ; Food ; Fraud ; Jurisprudence ; Labeling ; Law ; Legal institutions ; Marijuana ; Politics ; Propaganda ; Science ; Speech ; Speeches ; Supreme courts ; Tobacco industry</subject><ispartof>The American University law review, 2022-01, Vol.71 (6), p.2157-2242</ispartof><rights>Copyright American University Law Review 2022</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,12845</link.rule.ids></links><search><creatorcontrib>Angelatos, David</creatorcontrib><title>MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT</title><title>The American University law review</title><description>From "Reefer Madness" to "This Is Your Brain on Drugs," Americans have lived through decades of anti-cannabis propaganda. Legalization is poised to turn this information environment on its head, unleashing a torrent of corporate-funded, pro-cannabis misinformation that regulators cannot prevent or dispel. This appears to be a problem caused by the Supreme Court's creation and expansion over the past fifty years of First Amendment protections for corporate and commercial speech. Although these doctrines contribute substantially to the problem, this Article shows how it originates in lax antitrust policy rather than expansive First Amendment jurisprudence. If Congress follows current legalization trends and facilitates the creation of a consolidated commercial cannabis industry, misinformation about marijuana will follow. That industry will have the opportunity, incentive, and ability to draw on successful disinformation campaigns waged by other big businesses, including the tobacco and food-and-beverage industries, to corrupt both the public's understanding of cannabis science and the science itself. Even with the benefit of foresight, legal institutions are hamstrung in their response to this problem. The First Amendment's protections of corporate and commercial speech foreclose many of the regulatory options. Several options remain, including fraud prosecutions, government speech identifying cannabis's health effects, and administrative regulation of labeling and advertising. But these responses are incomplete, inadequate, and vulnerable to industry capture, constitutional invalidation, and corporate evasion. Ultimately, misinformation about marijuana is an unavoidable cost of a consolidated cannabis industry. Even abolishing the corporate and commercial speech doctrines, although helpful, would not get at the root problem: excessive private power. To effectively address the threat of corporate-funded misinformation about cannabis science, Congress must prevent the creation of a consolidated industry by ratifying and bolstering the existing state bans on interstate and international commerce in cannabis, among other measures.</description><subject>Activists</subject><subject>Advertising</subject><subject>Alcohol</subject><subject>Antitrust</subject><subject>Beverage industry</subject><subject>Cannabis industry</subject><subject>Commercial speech</subject><subject>Commercialization</subject><subject>Decriminalization</subject><subject>Enforcement</subject><subject>False information</subject><subject>First Amendment-US</subject><subject>Food</subject><subject>Fraud</subject><subject>Jurisprudence</subject><subject>Labeling</subject><subject>Law</subject><subject>Legal institutions</subject><subject>Marijuana</subject><subject>Politics</subject><subject>Propaganda</subject><subject>Science</subject><subject>Speech</subject><subject>Speeches</subject><subject>Supreme courts</subject><subject>Tobacco industry</subject><issn>0003-1453</issn><issn>1943-5673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7UB</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNit0KgjAAhUcUZD_vMOg2Ybap2d3SiQu3wZwEQUgXdiGR5fL9s-gBujgcvnO-EXC8iGDXD0I8Bg5CCLse8fEUzKxtPrglxAFnwQsuU6UFNVxJSPeqNFBQzQ8llXQHYyUE0zGnOT99lfUwyULlPPkhlQk0GYOSHWHKdWEgFUwmQ8wCTK6Xm62Xv56DVcpMnLmPrn32tX1VTdt39-GqNmHgIRz4JML_WW8--zv0</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Angelatos, David</creator><general>American University Law Review</general><scope>0-V</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>4U-</scope><scope>7UB</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>8AM</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGRYB</scope><scope>CCPQU</scope><scope>DPSOV</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K60</scope><scope>K6~</scope><scope>K7.</scope><scope>K9.</scope><scope>KC-</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2L</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20220101</creationdate><title>MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT</title><author>Angelatos, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_27610365493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Activists</topic><topic>Advertising</topic><topic>Alcohol</topic><topic>Antitrust</topic><topic>Beverage industry</topic><topic>Cannabis industry</topic><topic>Commercial speech</topic><topic>Commercialization</topic><topic>Decriminalization</topic><topic>Enforcement</topic><topic>False information</topic><topic>First Amendment-US</topic><topic>Food</topic><topic>Fraud</topic><topic>Jurisprudence</topic><topic>Labeling</topic><topic>Law</topic><topic>Legal institutions</topic><topic>Marijuana</topic><topic>Politics</topic><topic>Propaganda</topic><topic>Science</topic><topic>Speech</topic><topic>Speeches</topic><topic>Supreme courts</topic><topic>Tobacco industry</topic><toplevel>online_resources</toplevel><creatorcontrib>Angelatos, David</creatorcontrib><collection>ProQuest Social Sciences Premium Collection</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Worldwide Political Science Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Criminology Collection</collection><collection>ProQuest One Community College</collection><collection>Politics Collection</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Criminal Justice Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Political Science Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American University law review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Angelatos, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT</atitle><jtitle>The American University law review</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>71</volume><issue>6</issue><spage>2157</spage><epage>2242</epage><pages>2157-2242</pages><issn>0003-1453</issn><eissn>1943-5673</eissn><abstract>From "Reefer Madness" to "This Is Your Brain on Drugs," Americans have lived through decades of anti-cannabis propaganda. Legalization is poised to turn this information environment on its head, unleashing a torrent of corporate-funded, pro-cannabis misinformation that regulators cannot prevent or dispel. This appears to be a problem caused by the Supreme Court's creation and expansion over the past fifty years of First Amendment protections for corporate and commercial speech. Although these doctrines contribute substantially to the problem, this Article shows how it originates in lax antitrust policy rather than expansive First Amendment jurisprudence. If Congress follows current legalization trends and facilitates the creation of a consolidated commercial cannabis industry, misinformation about marijuana will follow. That industry will have the opportunity, incentive, and ability to draw on successful disinformation campaigns waged by other big businesses, including the tobacco and food-and-beverage industries, to corrupt both the public's understanding of cannabis science and the science itself. Even with the benefit of foresight, legal institutions are hamstrung in their response to this problem. The First Amendment's protections of corporate and commercial speech foreclose many of the regulatory options. Several options remain, including fraud prosecutions, government speech identifying cannabis's health effects, and administrative regulation of labeling and advertising. But these responses are incomplete, inadequate, and vulnerable to industry capture, constitutional invalidation, and corporate evasion. Ultimately, misinformation about marijuana is an unavoidable cost of a consolidated cannabis industry. Even abolishing the corporate and commercial speech doctrines, although helpful, would not get at the root problem: excessive private power. To effectively address the threat of corporate-funded misinformation about cannabis science, Congress must prevent the creation of a consolidated industry by ratifying and bolstering the existing state bans on interstate and international commerce in cannabis, among other measures.</abstract><cop>Washington</cop><pub>American University Law Review</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-1453 |
ispartof | The American University law review, 2022-01, Vol.71 (6), p.2157-2242 |
issn | 0003-1453 1943-5673 |
language | eng |
recordid | cdi_proquest_journals_2761036549 |
source | Worldwide Political Science Abstracts; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; HeinOnline Law Journal Library; Alma/SFX Local Collection |
subjects | Activists Advertising Alcohol Antitrust Beverage industry Cannabis industry Commercial speech Commercialization Decriminalization Enforcement False information First Amendment-US Food Fraud Jurisprudence Labeling Law Legal institutions Marijuana Politics Propaganda Science Speech Speeches Supreme courts Tobacco industry |
title | MISINFORMATION ABOUT MARIJUANA: COMMERCIALIZATION, CONSOLIDATION, AND THE NEW FIRST AMENDMENT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A43%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MISINFORMATION%20ABOUT%20MARIJUANA:%20COMMERCIALIZATION,%20CONSOLIDATION,%20AND%20THE%20NEW%20FIRST%20AMENDMENT&rft.jtitle=The%20American%20University%20law%20review&rft.au=Angelatos,%20David&rft.date=2022-01-01&rft.volume=71&rft.issue=6&rft.spage=2157&rft.epage=2242&rft.pages=2157-2242&rft.issn=0003-1453&rft.eissn=1943-5673&rft_id=info:doi/&rft_dat=%3Cproquest%3E2761036549%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2761036549&rft_id=info:pmid/&rfr_iscdi=true |